Descrizione

Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population.

Figure 2

Forest Plot

Source Paper

Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review.

Antibiotics (Basel, Switzerland) (2015)

PMID: 27025619

DOI: 10.3390/antibiotics4020160

Cite This Figure

![Figure 2: Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population.]()

> Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." *Antibiotics (Basel, Switzerland)*, 2015. PMID: [27025619](https://pubmed.ncbi.nlm.nih.gov/27025619/)

<figure>
  <img src="" alt="Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population." />
  <figcaption>Figure 2. Pooled effect estimates from randomized trials evaluating probiotic supplementation for primary and secondary prevention of Clostridium difficile infections are presented, with subgroup analyses by probiotic strain and patient population.<br>  Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." <em>Antibiotics (Basel, Switzerland)</em>, 2015. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27025619/">27025619</a></figcaption>
</figure>

Evidenze correlate

Saccharomyces boulardii per Antibiotic-Associated Diarrhea (AAD)

Grado A · 25 studi

Saccharomyces boulardii per Clostridioides difficile Infection (CDI)

Grado B · 6 studi

Saccharomyces boulardii per Traveler's Diarrhea

Grado B · 4 studi

Lactobacillus casei per Antibiotic-Associated Diarrhea (AAD)

Grado C · 3 studi